News
Commemorating the centenary of late Dr. Y. V. S. Murthy (1927–2010), Andhra University and community leaders reflect on the enduring legacy of the chemical engineering visionary and founder of Alkali Metals Limited. Through his namesake campus auditorium and the dedicated work of the Dr. Y. V. S. Murty Charitable Trust, his commitment to human dignity and social welfare remains as vibrant as ever.
Surinder Koli, the prime accused in the infamous 2006 Nithari serial killings who was acquitted by the Supreme Court in 2025, was found dead in Haridwar on September 18. The incident followed a national seminar in Visakhapatnam where senior jurists and media professionals scrutinized investigative lapses by the CBI and questioned the lack of media follow-up for the victims’ families.
In a startling turn of events, Surinder Koli, the prime accused in the 2006 Nithari serial killings who was acquitted by the Supreme Court in 2025, was found dead inside his Haridwar tea stall on September 18. The incident closely follows a national seminar in Visakhapatnam where senior jurists and experts scrutinized the press and the CBI over systemic investigative failures that denied justice to victim families.
The latest chapter of Indian football’s fiercest rivalry ended in a dramatic 1-1 tie, leaving the ISL title race completely unresolved. After Edmund Lalrindika put East Bengal ahead late in the game, Jason Cummings struck a 90th-minute equalizer to keep both teams level at the top of the table.
15th may | India The Supreme Court on Thursday expressed concern over the Centre’s 2023…
15th May | Dalal Street Dalal Street shook off a shaky start on Thursday to…
15th May | India On May 14, 2026, the Election Commission of India (ECI) officially…
The sudden passing of 38-year-old Prateek Yadav due to a massive blood clot has shocked Uttar Pradesh. Despite his focus on fitness and business, medical complications following a recent surgery led to a fatal heart and lung failure, bringing together political rivals in a moment of shared grief.
In a milestone for neurological care, Eli Lilly has officially introduced Lormalzi (donanemab) to the Indian market as of May 2026. As the first “disease-modifying” therapy available domestically, the drug marks a departure from symptom management by actively removing amyloid plaques from the brain. Priced at ₹91,688 per vial, the intravenous infusion is administered every four weeks and can potentially be stopped once plaque clearance is achieved. With India’s dementia cases projected to more than double by 2036, the CDSCO-approved treatment, supported by a specialized “alternative access program,” represents a critical shift toward active medical intervention for the country’s aging population.
Advertisement
